ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 911

How Well Do Rheumatology Fellows Manage Acute Infusion Reactions?  a Pilot Curricular Intervention

Jason Weiner1, Amanda M. Eudy2 and Lisa Criscione-Schreiber3, 1Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, 2Duke University Medical Center, Chapel Hill, NC, 3Internal Medicine, Duke University Medical Center, Durham, NC

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Curriculum, Education, Fellow-In-Training, infusions and reactions, medical

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Education

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Infusible DMARDs are commonly prescribed in rheumatology and other fields. There are no published formal educational curricula rheumatology fellowship programs can use to teach infusion reaction management skills to fellows.  We aimed to better understand this educational gap, and implement and assess the effectiveness of an experiential curriculum on acute infusion reaction management.

Methods:

We included current rheumatology fellows and recent graduates from five fellowship programs.  Using a novel behavioral checklist, we assessed fellowsÕ performance managing an infusion reaction in a simulation, followed by a didactic focused on infusion reactions.  Pre and post-surveys assessed experiences to determine relevance, as well as attitudes and knowledge.

Results:

Despite ubiquitous prescribing of infusible biologic DMARDs, >50% of fellows were uncomfortable managing infusion reactions and 11% preferred prescribing injections because of these concerns.  Only 11% of fellows reported infusion reaction training during fellowship, but 56% reported managing actual patient infusion reactions.  Graduates reported similar experiences with 67% currently utilizing infusion services within their immediate clinic areas and 50% having managed actual patient infusion reactions.  Furthermore, all graduates reported no specific training requirements prior to prescribing infusible DMARDs in their current practice.  In the simulated infusion reaction, fellows managed grade 1 reactions appropriately, but grade 4 reactions poorly, meeting <50% of objectives.  All fellows discontinued the infusion in the setting of anaphylaxis, but only 56% administered epinephrine.  There was no difference in performance or written knowledge by training year.  All fellows felt more prepared to manage infusion reactions post-curriculum and were satisfied with the experience.  All graduates recommended fellows receive education on this topic.

Conclusion:

We confirmed an education gap in rheumatology fellowship training regarding infusion reactions, both in knowledge and performance.  We developed and implemented a brief experiential curriculum including simulation of a high-risk patient care scenario.  This curriculum was well received and is easily exportable to other programs and fields of medicine.




Disclosure: J. Weiner, None; A. M. Eudy, None; L. Criscione-Schreiber, None.

To cite this abstract in AMA style:

Weiner J, Eudy AM, Criscione-Schreiber L. How Well Do Rheumatology Fellows Manage Acute Infusion Reactions?  a Pilot Curricular Intervention [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/how-well-do-rheumatology-fellows-manage-acute-infusion-reactions-a-pilot-curricular-intervention/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-well-do-rheumatology-fellows-manage-acute-infusion-reactions-a-pilot-curricular-intervention/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology